Pharmacogenomics arrives

AUTOR(ES)
FONTE

BioMed Central

RESUMO

We've had the human genome sequence for a little while now, and it looks as though we're still some way off being able to exclude from most clinical trials those people who will probably suffer side effects.

Documentos Relacionados